Systemic cardiovascular response in hemodialysis without and with ultrafiltration with membranes of high and low biocompatibility.

In order to test whether dialyzer membrane biocompatibility influences systemic cardiovascular function, we treated 8 hemodialysis patients (4 men and 4 women, aged 24-73 years) with a low-biocompatible (cuprophane) and a high-biocompatible (polyacrylonitrile) membrane in a randomized double-blind crossover protocol using bicarbonate hemodialysis without ultrafiltration for the first 60 min and with ultrafiltration for the remaining treatment time. Left ventricular function and systemic hemodynamics were assessed noninvasively at baseline and during treatment by Doppler echocardiography combined with external subclavian artery pulse trace calibrated with oscillometrically measured brachial artery blood pressures. There was no significant difference in the cardiovascular response to the 2 membranes, neither during isolated hemodialysis nor when ultrafiltration was added. Mean arterial pressure increased 10% (p < 0.001) during isolated hemodialysis and returned to baseline levels with ultrafiltration. The cardiac index decreased 22% (p < 0.001) during ultrafiltration, due to the greater decrease in left ventricular stroke index (30%, p < 0.001) than increase in heart rate (9%, p < 0.05). Total peripheral resistance increased 10% (p < 0.05) during isolated hemodialysis and a further 19% (p < 0.01) when ultrafiltration was added. Hence, profound cardiovascular alterations were observed during hemodialysis treatment; however, these changes were not related to the biocompatibility of the membranes.

A new method for echocardiographic computerized three-dimensional reconstruction of left ventricular endocardial surface: in vitro accuracy and clinical repeatability of volumes.

This study evaluates the in vitro accuracy and clinical repeatability of volumes derived by a new algorithm for three-dimensional reconstruction of cavity surfaces based on echocardiographic apical images obtained by probe rotation. The accuracy of the method was tested in latex phantoms (true volumes, 32 to 349 cm3) with (n = 9) or without (n = 9) rotational symmetry around the midcavitary long axis. Repeatability of left ventricular volumes was assessed in subjects without (n = 5) or with (n = 10) myocardial disease. Estimated phantom volumes obtained from four (three) imaging planes were close to true volumes with a mean difference +/- SD of 0 +/- 2 (2 +/- 3) cm3 in symmetric and 1 +/- 3 (4 +/- 4) cm3 in asymmetric objects. Biplane and single-plane volume estimates were less accurate. Interobserver and intraobserver repeatability of three-dimensional left ventricular volumes was good for analysis (coefficients of variation: 3.5% to 6.2%) and was lower for recording (coefficients of variation: 7.4% to 10.9%). Hence the present algorithm reproduces volumes of symmetric and deformed in vitro objects accurately over a wide range of size and shape, and it produces repeatable left ventricular volumes in the clinical situation.

Three-dimensional echocardiography for quantitative left ventricular wall motion analysis: a method for reconstruction of endocardial surface and evaluation of regional dysfunction.

A method for quantitative LV wall motion analysis based on 3-D reconstruction of the LV endocardial surface is presented. The reconstruction is based on a minimum of three transthoracic apical 2-D cineloops of the LV, digitally transferred from the ultrasound scanner to a computer. Images are obtained by rotating the transducer around the LV long axis. Endocardial borders are traced with an automatic edge detection algorithm with manual correction. These borders are used with a specially designed computer algorithm for reconstruction of LV cavity 3-D shape, and LV volumes, ejection fraction, and endocardial surface area can be determined. The end-diastolic and end-systolic endocardial surfaces are compared for analysis of regional wall motion. A threshold value is selected to discriminate between normal and abnormal wall motion. Regional wall motion abnormalities are displayed in a bull's eye plot, and the corresponding endocardial surface area is expressed in percent of the total endocardial area. Phase analysis is performed from reconstruction of the endocardial surface throughout the cardiac cycle, and displays regions with abnormal wall motion as being out of phase with LV volume variation. Thus, LV 3-D reconstruction performed by this method can be used for quantitative analysis of wall motion in several clinical situations, and due to the simplicity of processing the data, can be useful outside the research laboratory.

Digital dipyridamole stress echocardiography in silent ischemia after coronary artery bypass grafting and/or after healing of acute myocardial infarction.

This study evaluates dipyridamole stress echocardiography in silent ischemia. Fourteen patients with previous coronary artery bypass grafting (group A) and 16 patients with healed myocardial infarction (group B) were studied. All had > or = 1 mm ST depression without chest pain during bicycle exercise testing. Left ventricular wall motion was analyzed using a computerized display of digital systolic cineloops with a high frame rate. Test results were compared with coronary angiography. Dipyridamole echocardiography accurately identified patients with significant coronary artery stenosis in both groups (3 of 4 in group A, 11 of 14 in group B). Retrograde flow to the occluded native artery was associated with positive results on dipyridamole testing in 6 of 7 patients in group A and all 3 in group B. Sensitivity, specificity and diagnostic accuracy for detecting significant coronary stenosis or occlusions with retrograde flow was 78, 100 and 83%, respectively. Patients with angiographic multivessel disease had a significantly larger increase in wall motion score index during dipyridamole stress than patients with 0- or 1-vessel disease, 0.18 +/- 0.11 versus 0.05 +/- 0.18 (p < 0.05). Two patients developed symptomatic bradycardia and hypotension during dipyridamole infusion. It is concluded that dipyridamole echocardiography accurately identifies myocardial regions with restricted coronary flow. Stress echocardiography is a valuable tool for assessing coronary flow in silent ischemia.

Noninvasive computerized assessment of left ventricular performance and systemic hemodynamics by study of aortic root pressure and flow estimates in healthy men, and men with acute and healed myocardial infarction.

Aortic root pressure and flow data can be used to assess left ventricular (LV) performance and properties of the systemic arterial tree. The calibrated subclavian arterial pulse trace was combined with echocardiographic imaging and Doppler velocity recordings to obtain noninvasive estimates of aortic root pressure and flow in 8 healthy subjects (group A), 12 patients with recent myocardial infarction (group B), and 8 with healed myocardial infarction and a dilated left ventricle (group C). The pressure and flow data were transferred to a computer and processed in specially designed software, including a new procedure for estimation of 3-element windkessel model parameters. There were no significant group differences for either aortic root pressure estimates or heart rate. In groups B and C, stroke and cardiac indexes were lower and total peripheral resistance higher than in group A. There were no group differences in the model estimates of total arterial compliance, whereas the characteristic impedance was greater in group C than in A, indicating a less compliant aorta in C. Both LV total and steady power were less in groups B and C than in A, whereas no group difference was found for percent oscillatory power. The reproducibility for recording was good for the aortic root pressure estimates, and lower for the derived parameters (stroke and cardiac indexes, windkessel model parameters and LV power), whereas that for interpretation was generally good. This method provides a unique noninvasive access to important parameters of LV function and the systemic circulation.